NCI @ the 2024 World Cancer Congress

September 17 – September 19, 2024

International Conference Center Geneva Geneva, Switzerland

Add to Outlook Calendar

The National Cancer Institute (NCI) and the Center for Global Health (CGH) are participating in several scientific and rapid fire oral abstract sessions at the Union for International Cancer Control 2024 World Cancer Congress, September 17-19, 2024 in Geneva, Switzerland. 

View the 2024 World Cancer Congress programme
(All times listed below are in CET)

Scientific Sessions with NCI Staff

Format	Session	Location	Date | Time
In-person	2023 Global Review of National Cancer Control Plans: Implications for Research, Policy, and Practice	Room 8	September 17th - 2:20 - 3:20 PM
In-person	New and old challenges in tobacco control: advancing innovative measures while ensuring implementation of established ones	Plenary E	September 18th - 3:40 - 4:40 PM
In-person	How can behavioral science and implementation science help cancer health systems to regain lost ground post-pandemic and strengthen provision to address cancer burden in the future? Insights from research and innovation in the Global South, EU, UK, and US	Plenary C	September 18th - 4:40 - 5:40 PM
In-person	Women, power, and cancer: towards equitable, gender-transformative cancer prevention, care, and control	Amphitheatre D	September 19th - 8:30 - 9:30 AM
In-person	Forward looking tobacco policies in an age of political uncertainty	Plenary C	September 19th - 11:10 AM -12:10 PM
Digital	Supportive Care: Co-creating resources for sustainability and scaling	N/A	N/A

Scientific Abstracts with NCI Authors

Abstract Type	Title	Location	Date | Time
Rapid Fire	Effect of "No Safe Level" Risk Relationship Messaging on Perceptions of Alcohol Use and Cancer Risk	Room 4	September 18th - 3:10 - 4:10 PM
Rapid Fire	Targeting Cervical Cancer Elimination and the Global Breast Cancer Initiative in The Americas through telementoring: A PAHO and MD Anderson Collaboration	Room 4	September 18th - 4:10 - 4:40 PM
Rapid Fire	Priorities and Challenges to Cancer Therapeutic Clinical Trials in Low- and Middle-Income Countries: Insights from a Global NCI Survey	Room 4	September 19th - 9:40 - 10:40 AM
E-Library	An overview of the U.S. National Cancer Institute's (NCI) 2023 international research portfolio in low- and middle-income countries (LMICs)	N/A	N/A

 

Meet the Experts at the NCI Booth - Stand #7-8